2상모집 중단 (진행 중)

Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

연구 개요

The main purpose of this study is to find out the good and the bad effects that the combination of cetuximab with the traditional chemotherapy regimen of cisplatin, doxorubicin, and cyclophosphamide has when given to patients with later stage thymoma or thymic carcinoma before surgery. The physicians will also look at changes in genes in the tumor that may relate to the effectiveness of cetuximab

스폰서: 협력: 일라이 릴리
적응증: Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA
중재: Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
목표 등록: 18명
시작일: 2009-12-01
완료(예정): 2026-12-01
등록번호: NCT01025089 · ClinicalTrials.gov ↗

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.